Search results
Found 30060 matches for
A review of public comments on a proposed FDA regulatory framework, for modifications to artificial intelligence and machine learning-based software as a medical device, has found that 63% came from parties with financial ties to industry, and that the majority, 86% did not cite any scientific evidence.
UCB-Translational Pharmacology Scholarship
Applications for this project will open soon.
Norman Collisson Foundation Scholarship
Applications for this project are now closed.
Themes
OCTRU runs trials across multiple areas of medicine. Within OCTRU there are five core therapeutic areas of expertise, although trials are also undertaken outside of these areas and groups.
Meet the team
-
Gary Collins
Professor of Medical Statistics and Director of CSM
-
Andrew Carr
Nuffield Professor of Orthopaedics
Funded by
